89 related articles for article (PubMed ID: 22800482)
1. [Application of combined telomerase activity analysis and immunocytochemistry in cytopathologic diagnosis].
Liu Y; Xu ML; Wang J; Wu BQ; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):181-5. PubMed ID: 22800482
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic implications of telomerase activity in pleural effusions.
Dikmen G; Dikmen E; Kara M; Sahin E; Doğan P; Ozdemir N
Eur Respir J; 2003 Sep; 22(3):422-6. PubMed ID: 14516130
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer.
Liu L; Liu B; Zhu LL; Zhang W; Li Y
Bioanalysis; 2012 Oct; 4(19):2367-74. PubMed ID: 23088463
[TBL] [Abstract][Full Text] [Related]
5. [Diagnotic value of the combined determination of telomerase activity in induced sputum, pleural effusion and fiberobronchoscopic biopsy samples in lung cancer].
Li H; Hua F; Zhao C; Liu G; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):128-31. PubMed ID: 20673505
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in benign and malignant cytologic fluids.
Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
[TBL] [Abstract][Full Text] [Related]
7. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
8. Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.
Li W; Ni Y; Tu Z; Wu S; Wu Z; Zheng S
Eur J Cardiothorac Surg; 2009 Sep; 36(3):460-4. PubMed ID: 19502078
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion].
Li H; Fu J; Xiu Y; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):652-4. PubMed ID: 20681457
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
Adell E; Dejmek A
Diagn Cytopathol; 2014 Dec; 42(12):1051-7. PubMed ID: 24692425
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
Yang Z; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease.
Xinarianos G; Scott FM; Liloglou T; Prime W; Turnbull L; Walshaw M; Field JK
Lung Cancer; 2000 Apr; 28(1):37-42. PubMed ID: 10704707
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Storage Solution Type and Prolonged Storage on the Immunoreactivity of Cells.
Ikeda K; Sato S; Chigira H; Shibuki Y; Hiraoka N
Acta Cytol; 2020; 64(4):352-359. PubMed ID: 31597129
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
Shu J; Sun GY; Liu AP; Liu J
Clin Chim Acta; 2007 Jun; 381(2):131-5. PubMed ID: 17399696
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases.
Hiyama K; Ishioka S; Shay JW; Taooka Y; Maeda A; Isobe T; Hiyama E; Maeda H; Yamakido M
Int J Mol Med; 1998 Mar; 1(3):545-9. PubMed ID: 9852260
[TBL] [Abstract][Full Text] [Related]
17. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
18. Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid.
Arai T; Yasuda Y; Takaya T; Ito Y; Hayakawa K; Toshima S; Shibuya C; Yoshimi N; Kashiki Y
Oncol Rep; 1998; 5(2):405-8. PubMed ID: 9468568
[TBL] [Abstract][Full Text] [Related]
19. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
[TBL] [Abstract][Full Text] [Related]
20. Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.
Dikmen E; Kara M; Dikmen G; Cakmak H; Dogan P
Eur J Cardiothorac Surg; 2003 Feb; 23(2):194-9; discussion 199-20. PubMed ID: 12559342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
